Open AccessSUI AND TVT IUS ND TVT SECURE SYSTEM: A PROSPECTIVE OBSERVATIONAL MULTICENTRIC STUDY. MORBIDITY AND SHORT-TERM PERCENTAGES OF SUCCESS
Author(s) -
F. Bernasconi,
Valeria Napolitano,
Mario Primicerio,
Davide Lijoi,
Edoardo Leone,
F. Armitano,
Massimo Luerti,
G.C. Sugliano,
Domenico Vitobello,
Diego Della Riva,
Darío Gregori
Publication year - 2010
Publication title -
urogynaecologia international journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.103
H-Index - 7
eISSN - 2038-8314
pISSN - 1121-3086
DOI - 10.4081/uij.2009.3.31
Subject(s) - medicine , sling (weapon) , occult , urinary incontinence , surgery , perioperative , population , observational study , urology , gynecology , alternative medicine , pathology , environmental health
The aim of this study was to evaluate perioperative morbidity and shortterm efficacy of TVT-Secur in treating female stress urinary incontinence. Data from 147 patients with urodynamic and/or occult SUI who were treated with TVTsecur in each single centre between 1st March 2007 and 31st December 2007 were collected. In positioning the sling, 74.8% of the surgeons chose the transobturator approach (110/147) and the remaining 25.2% chose the retropubic one. In 64.6% of patients (95/147) with urethral hypermobility and cystocoele =<2° degree according to POP-Q classification system, only isolated urodynamic SUI was treated (Group A); in 52 patients TVTsecur was used to treat an occult SUI associated with complex genital prolapse (Group B). Intra-operative complications were observed in the whole population: 2 slings had to be re-positioned; 1 deep vaginal laceration occurred and a new sling was implanted; 5 patients presented PE >=200ml. Post-operative morbidity was represented by 1 haematoma that disappeared spontaneously; 1 case of temporary pain that stopped within 7 days; 8 patients had urinating difficulties (RV>100ml), 5 of whom were in Group B. At the short-term follow up this technique’s success percentage with respect to the total population was 87.5% (119/136), 85.3% in Group A (81/95) and 90.3% (37/41) in Group B. The data collected show that when treating female stress urinary incontinence, TVTsecur represents an innovative, simpler and safer, therapeutic alternative, and its efficacy equals that of retropubic and/or transobturator traditional midurethral slings.